Orion OyjORINF +4.81%100 Operating Margin % is 27.46% as of Mar. 2026, which is 4% above its 10-year median of 26.29. GuruFocus rates ORINF with a GF Score™ of 100/100 and a GF Value™ of $86.78. The stock has 2 warning signs investors should review. Among 955 Drug Manufacturers companies, Orion Oyj ranks better than 96.65% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Orion Oyj's Operating Income for the
three
months ended in Mar. 2026 was $133 Mil. Orion Oyj's Revenue for the
three
months ended in Mar. 2026 was $483 Mil. Therefore, Orion Oyj's Operating Margin % for the quarter that ended in Mar. 2026 was 27.46%.
Good Sign:
Orion Oyj operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Orion Oyj's Operating Margin % or its related term are showing as below:
ORINF'
s Operating Margin % Range Over the Past 10 Years
Min: 22.29 Med: 26.29 Max: 34.24
Current: 34.24
ORINF's Operating Margin % is ranked better than 96.65% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.45
vs ORINF: 34.24
Orion Oyj's 5-Year Average Operating Margin % Growth Rate was 4.10% per year.
Orion Oyj's Operating Income for the
three
months ended in Mar. 2026 was $133 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was $780 Mil.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Orion Oyj Operating Margin % Related Terms
Orion Oyj Operating Margin % Historical Data
* Premium members only.
The historical data trend for Orion Oyj's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ORINF vs LLY, JNJ, ABBV: Operating Margin % Comparison
For the Drug Manufacturers - General subindustry, Orion Oyj's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orion Oyj Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Orion Oyj's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Orion Oyj's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Orion Oyj's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orion Oyj (ORINF) has a Operating Margin % of 27.46% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Orion Oyj and its competitors. This is near median its historical median of 26.29. Over the past decade, Orion Oyj's Operating Margin % has ranged from 22.29 to 34.24. According to the industry distribution chart, Orion Oyj ranks #32 out of 955 companies in the Drug Manufacturers industry, placing it in the top 3.4%.
Is Orion Oyj's Operating Margin % too high?
Orion Oyj's current Operating Margin % of 27.46% is near median its 10-year median of 26.29. Over the past 10 years, this metric has ranged from a low of 22.29 to a high of 34.24. The Drug Manufacturers industry median Operating Margin % is 7.45. Orion Oyj's value of 27.46% is 268.6% above this industry median. Based on the distribution chart, Orion Oyj ranks #32 out of 955 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Orion Oyj has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Orion Oyj's Operating Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Orion Oyj ranks #32 out of 955 companies for Operating Margin %. This places Orion Oyj in the top 3% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 7.45. Orion Oyj's value of 27.46% is 268.6% above this benchmark. Historically, Orion Oyj's own Operating Margin % has ranged from 22.29 to 34.24 over the past decade. While the company's 10-year median is 26.29 vs. the industry median of 7.45, Orion Oyj has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orion Oyj's current Operating Margin % of 27.46% is 268.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Orion Oyj and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orion Oyj's current Operating Margin % is 27.46%, which is near median its own 10-year median of 26.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Oyj stock overvalued right now?
Orion Oyj (ORINF) has a current Operating Margin % of 27.46%. The stock's GF Value™ is $86.78, compared to a current price of $82.75 — trading 4.6% below its estimated fair value. The current Operating Margin % is 27.46%, which is near median its 10-year median of 26.29 and 268.6% above the Drug Manufacturers industry median of 7.45. Orion Oyj's overall GF Score™ is 100/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Orion Oyj (ORINF), the current Operating Margin % is 27.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orion Oyj (ORINF) Overvalued in 2026?
Based on GuruFocus' analysis, Orion Oyj stock appears to be undervalued.
The current stock price of $82.75 is trading 4.6% below its estimated GF Value™ of $86.78.
Key valuation signals for ORINF:
Operating Margin %: 27.46% (near median its 10-year median of 26.29)
GF Value™: $86.78 vs. price of $82.75 (4.6% below fair value)
Industry Position: 268.6% above the Drug Manufacturers median (#32 of 955)
No single metric tells the full story. See the ORINF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
100GF Score
Get the complete analysis for ORINF
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ORINF has been successfully added to your 
